指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

抗菌药物短缺期间对推荐药物的依从性与使用情况

Adherence to antimicrobial agent recommendations and utilization during drug shortages.
指南 / 共识 · Am J Health Syst Pharm · 2023-01-01
一句话结论抗菌药物短缺期间限制策略显著降低短缺药物使用,但依从性仅57%,视觉提示可提高依从性(99% vs 94%,P=0.03)。

该研究回顾2015至2020年5种因短缺而受限的抗菌药物,对每个限制期内接受短缺药物的住院患者进行病历审查,以确定影响依从性的因素,并用每1000患者日的治疗天数分析短缺期间及解除后的使用情况。266例接受短缺药物的患者中,151例(57%)依从限制标准;美罗培南、氨苄西林/舒巴坦和哌拉西林/他唑巴坦依从性最高。非依从组中位疗程短于依从组(4天 vs 2天,P<0.0001)。使用病历中的视觉提示可提高依从性(99% vs 94%,P=0.03)。短缺解除后,除美罗培南和甲硝唑恢复至基线外,其余药物使用量超过基线;短缺期间1至2种推荐替代药物的使用显著增加。

要点

  • 266例接受短缺抗菌药物的患者中,仅151例(57%)依从既定限制标准。
  • 非依从组中位疗程为2天,短于依从组的4天(P<0.0001)。
  • 使用病历视觉提示者依从率为99%,未使用者为94%(P=0.03)。
  • 脓毒症排查、手术预防和尿路感染等适应症更易出现非依从。
  • 短缺解除后,除美罗培南和甲硝唑恢复至基线外,其余短缺药物使用量均超过基线。

适用人群与场景

  • 2015年至2020年期间因短缺而限制使用的5种抗菌药物所涉及的住院患者。

研究设计与关键结果

  • 研究类型为病历回顾分析,纳入266例接受短缺抗菌药物的患者,依从限制标准者151例(57%)。
  • 美罗培南、氨苄西林/舒巴坦和哌拉西林/他唑巴坦的依从性最高。
  • 非依从组中位疗程为2天,依从组为4天(P<0.0001)。
  • 脓毒症排查、手术预防和尿路感染等适应症更可能出现非依从。
  • 使用病历视觉提示者依从率为99%,未使用者为94%(P=0.03)。
  • 短缺和限制期间短缺药物使用量下降;短缺解除后,除美罗培南和甲硝唑恢复至基线外,其余药物使用量超过基线。
  • 短缺和限制期间,每种短缺药物对应的1至2种推荐替代药物使用量显著增加。

证据类型、等级与局限

  • 证据类型:病历回顾分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 当前限制策略显著降低了短缺抗菌药物的使用,但依从性仍有提升空间;识别替代药物并提供视觉提示可提高依从性(作者结论)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Antimicrobial shortages occur frequently, but the impact on antimicrobial use is not well defined. The study objectives were to characterize utilization of antimicrobial agents with established restrictions during a medication shortage, assess utilization of shortage antimicrobials following shortage resolution, and examine use of recommended alternative antimicrobials during the shortage period.

METHODS: Five antimicrobials were restricted due to shortages from 2015 through 2020. Chart review of inpatients receiving a shortage medication during each restriction period was performed to determine factors influencing adherence to established restriction criteria. To assess antimicrobial utilization during shortages and following shortage resolution, days of therapy per 1,000 patient days were analyzed for each shortage and alternative antimicrobial.

RESULTS: Across 266 patients receiving shortage antimicrobials, antimicrobial use was adherent to restriction criteria for 151 patients (57%). Meropenem, ampicillin/sulbactam, and piperacillin/tazobactam had the greatest adherence. Median duration of therapy was shorter in the nonadherent group than in the adherent group (4 vs 2 days, P < 0.0001). Shortage antimicrobial use was more likely to be nonadherent for indications such as sepsis rule out, surgical prophylaxis, and urinary tract infection. Adherence increased with use of visual cues in the chart (99% vs 94%, P = 0.03). Utilization of shortage agents decreased during shortage and restriction periods. After shortage resolution, utilization exceeded baseline usage for all agents except meropenem and metronidazole, for which usage returned to baseline. Utilization of 1 to 2 recommended alternative agents for each shortage agent significantly increased during the shortage and restriction periods.

CONCLUSION: Current strategies for restriction significantly decreased utilization of shortage antimicrobials, but additional opportunities exist. Identifying alternative agents and providing visual cues increased adherence.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

参考来源

  1. Urban V, Lee BR, Goldman JL, et al. Adherence to antimicrobial agent recommendations and utilization during drug shortages. Am J Health Syst Pharm. 2023. PMID: 36448681. doi:10.1093/ajhp/zxac355

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。